About
IrisVision is a cutting-edge assistive technology company that develops AI-powered wearable smart glasses for individuals suffering from low vision disorders. Developed in partnership with experts at Johns Hopkins University, IrisVision synthesizes neuroscience, augmented reality, and wearable mobile technology into a single, portable solution. The device is FDA-registered as a Class I medical device and is designed to address a wide range of ocular conditions including macular degeneration, diabetic retinopathy, Stargardt disease, retinitis pigmentosa, ocular albinism, optic neuropathy, and optic atrophy. The flagship LIVE 2.0 headset features a stunning 1440x3120 resolution display, multiple customizable vision modes (focus, scene, outline, and reading), robust connectivity, improved battery life, and an ultra-lightweight, portable form factor. Beyond hardware, IrisVision pairs every device with a community of trained Coaches who provide remote, personalized training sessions in the user's home, ensuring a tailored and comfortable onboarding experience. Users can try the device risk-free with a 30-day evaluation period and benefit from a one-year warranty with ongoing software updates and support. IrisVision is ideal for seniors, veterans, and anyone experiencing vision loss who wants to maintain their quality of life and daily independence.
Key Features
- Customizable Vision Modes: Offers multiple vision modes including focus, scene, outline, and reading to adapt to various daily activities and visual needs.
- High-Resolution Display: Delivers a superior visual experience with a 1440x3120 resolution screen built into a lightweight, portable wearable headset.
- Personalized Remote Coaching: Every device comes with access to a community of trained Coaches who provide remote, one-on-one training sessions from the comfort of the user's home.
- FDA-Registered Medical Device: Developed with low vision experts at Johns Hopkins University and registered as a Class I medical device, ensuring clinical credibility and safety.
- 30-Day Risk-Free Trial: Users can evaluate the device for 30 days and return it if it doesn't meet their needs, with a one-year warranty and ongoing software updates included.
Use Cases
- Helping seniors with macular degeneration read books, newspapers, and mail independently at home.
- Enabling veterans with vision loss from service-related injuries to regain daily independence and improve quality of life.
- Assisting individuals with diabetic retinopathy to watch TV, recognize faces, and engage in social activities.
- Supporting patients with retinitis pigmentosa in navigating their environment more safely through enhanced scene and outline vision modes.
- Providing clinicians and low vision specialists with a prescribable assistive technology solution for patients who are not candidates for surgical or optical correction.
Pros
- Clinically Backed Technology: Developed in partnership with Johns Hopkins experts and FDA-registered, giving users and caregivers confidence in its medical credibility.
- Highly Personalized Support: Remote coaching ensures every user gets tailored onboarding and training, improving adoption and long-term outcomes.
- Broad Condition Coverage: Supports a wide range of low vision disorders, making it applicable to a large population of visually impaired individuals.
Cons
- Premium Price Point: As a specialized medical-grade wearable device, IrisVision carries a high cost that may not be accessible to all users without insurance or financial assistance.
- Product Line Discontinuation: The LIVE 2.0 product line has been discontinued, which may raise concerns about long-term hardware support and future product availability.
- Limited to Vision Conditions: The device is purpose-built for low vision disorders and is not a general-purpose AR/wearable platform, limiting its versatility.
Frequently Asked Questions
IrisVision is designed to help individuals with macular degeneration, diabetic retinopathy, Stargardt disease, retinitis pigmentosa, ocular albinism, optic neuropathy, optic atrophy, and other ocular disorders.
Yes. IrisVision is an FDA-registered, Class I medical device developed in collaboration with low vision experts at Johns Hopkins University.
Yes. IrisVision offers a 30-day evaluation period during which you can return the device if it doesn't meet your expectations.
Every IrisVision device includes access to personalized remote coaching sessions from trained Coaches, a one-year warranty, and ongoing software updates and support.
IrisVision combines augmented reality, neuroscience, and wearable mobile technology. Its software lens technology delivers customizable vision modes and a high-resolution display to enhance the visual experience for low vision users.
